These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 23593605)

  • 1. Hepatitis C virus: virology and life cycle.
    Kim CW; Chang KM
    Clin Mol Hepatol; 2013 Mar; 19(1):17-25. PubMed ID: 23593605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
    McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
    J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatitis C virus life cycle as a target for new antiviral therapies.
    Pawlotsky JM; Chevaliez S; McHutchison JG
    Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets.
    Blight KJ; Kolykhalov AA; Reed KE; Agapov EV; Rice CM
    Antivir Ther; 1998; 3(Suppl 3):71-81. PubMed ID: 10726057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C Viral Replication Complex.
    Li HC; Yang CH; Lo SY
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33809897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two conserved histidines (His490 and His621) on the E2 glycoprotein of hepatitis C virus are critical for CD81-mediated cell entry.
    Qin ZL; Ju HP; Gao TT; Wang WB; Ren H; Zhao P; Qi ZT
    J Gen Virol; 2015 Jun; 96(Pt 6):1389-1399. PubMed ID: 25701820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palmitoylation of Hepatitis C Virus NS2 Regulates Its Subcellular Localization and NS2-NS3 Autocleavage.
    Wu MJ; Shanmugam S; Welsch C; Yi M
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antimalarial ferroquine is an inhibitor of hepatitis C virus.
    Vausselin T; Calland N; Belouzard S; Descamps V; Douam F; Helle F; François C; Lavillette D; Duverlie G; Wahid A; Fénéant L; Cocquerel L; Guérardel Y; Wychowski C; Biot C; Dubuisson J
    Hepatology; 2013 Jul; 58(1):86-97. PubMed ID: 23348596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel small molecule inhibitors against the NS3/4A protease of hepatitis C virus genotype 4a.
    El-Sayed SM; Ali MAM; El-Gendy BEM; Dandash SS; Issac Y; Saad R; Azab MM; Mohamed MR
    Curr Pharm Des; 2018; 24(37):4484-4491. PubMed ID: 30501598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Analysis of Hepatitis C Virus (HCV) Envelope Protein E1 Using a
    Tong Y; Chi X; Yang W; Zhong J
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28100619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
    Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.
    Haddad JG; Rouillé Y; Hanoulle X; Descamps V; Hamze M; Dabboussi F; Baumert TF; Duverlie G; Lavie M; Dubuisson J
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDB1 is a cellular substrate of NS3/4A protease and required for hepatitis C virus replication.
    Kang X; Chen X; He Y; Guo D; Guo L; Zhong J; Shu HB
    Virology; 2013 Jan; 435(2):385-94. PubMed ID: 23137809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.
    Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB
    J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Point Mutation in the N-Terminal Amphipathic Helix α
    Yan Y; He Y; Boson B; Wang X; Cosset FL; Zhong J
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A protocol for analyzing hepatitis C virus replication.
    Ren S; Contreras D; Arumugaswami V
    J Vis Exp; 2014 Jun; (88):e51362. PubMed ID: 24998302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete replication of hepatitis C virus in cell culture.
    Lindenbach BD; Evans MJ; Syder AJ; Wölk B; Tellinghuisen TL; Liu CC; Maruyama T; Hynes RO; Burton DR; McKeating JA; Rice CM
    Science; 2005 Jul; 309(5734):623-6. PubMed ID: 15947137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C Virus.
    Pietschmann T; Brown RJP
    Trends Microbiol; 2019 Apr; 27(4):379-380. PubMed ID: 30709707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load.
    Westhaus S; Deest M; Nguyen ATX; Stanke F; Heckl D; Costa R; Schambach A; Manns MP; Berg T; Vondran FWR; Sarrazin C; Ciesek S; von Hahn T
    J Hepatol; 2017 Aug; 67(2):237-245. PubMed ID: 28363797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection.
    Chen SH; Tan SL
    Curr Med Chem; 2005; 12(20):2317-42. PubMed ID: 16181135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.